524711 Stock Overview
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Vista Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹13.77 |
52 Week High | ₹19.70 |
52 Week Low | ₹7.95 |
Beta | 0.57 |
1 Month Change | 22.40% |
3 Month Change | -10.06% |
1 Year Change | 42.69% |
3 Year Change | 6.25% |
5 Year Change | -24.34% |
Change since IPO | 359.92% |
Recent News & Updates
Recent updates
Shareholder Returns
524711 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -1.6% | 1.4% | 2.8% |
1Y | 42.7% | 57.2% | 46.6% |
Return vs Industry: 524711 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 524711 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
524711 volatility | |
---|---|
524711 Average Weekly Movement | 7.5% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524711 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524711's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | n/a | Murali Meraga | www.vistapharmaceuticals.com |
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. The company was incorporated in 1991 and is based in Hyderabad, India.
Vista Pharmaceuticals Limited Fundamentals Summary
524711 fundamental statistics | |
---|---|
Market cap | ₹911.73m |
Earnings (TTM) | -₹84.77m |
Revenue (TTM) | ₹81.59m |
11.2x
P/S Ratio-10.8x
P/E RatioIs 524711 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524711 income statement (TTM) | |
---|---|
Revenue | ₹81.59m |
Cost of Revenue | ₹102.50m |
Gross Profit | -₹20.91m |
Other Expenses | ₹63.86m |
Earnings | -₹84.77m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.28 |
Gross Margin | -25.62% |
Net Profit Margin | -103.90% |
Debt/Equity Ratio | 24.0% |
How did 524711 perform over the long term?
See historical performance and comparison